Skip to content

Development of nursing care program to sustain the patients with recurrent lung cancer using "Hope-Design Note"

Development of nursing care program to sustain the patients with recurrent lung cancer using "Hope-Design Note" - Development of nursing care program to sustain the patients with recurrent lung cancer using "Hope-Design Note"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028219
Enrollment
5
Registered
2017-08-23
Start date
2017-09-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with recurrent lung cancer

Interventions

Session of nursing care program using &quot
Hope-Design Note&quot
Each session takes 30-60 minutes and we have 2 or 3 sessions. Session intervention is provided by the researcher using &quot
. Contents of intervention, the patient fills in the answer to the question of &quot
. What to write in the &quot
1 My family member or close friends and precious things for me 2 What I want to do for my family member or close friends and precious things for me If it is difficult for the patient to write in
, the researcher writes instead.

Sponsors

Tokyo Medical and Dental University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Patient has undergone surgery for lung cancer and received a diagnosis of recurrence 2 Patient can communicate in Japanese 3 Patient and their family know the patient's condition and treatment 4 Patient doesn't have serious cognative disorder and mental disease 5 Patient has physical status to endure examination

Exclusion criteria

Exclusion criteria: The primary physician estimate that patient cannot participate in the intervention or answer the questionnaire because of his/her physical,mental,or cognitive function.

Design outcomes

Primary

MeasureTime frame
1.The patients can express their hope 2.The patients can find the way of life in their future

Secondary

MeasureTime frame
1.Evaluation by hope scale: Herth Hope Index(HHI) 2.Evaluation by QOL scale: European Organization for Research Treatment of Cancer (EORTC QLQ-C30)

Countries

Japan

Contacts

Public ContactHisako Sanbe

Graduate School of Health Care Sciences, Tokyo Medical and Dental University Nursing Course of End-of Life care and Oncology

ns140012@tmd.ac.jp03-3813-7238

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026